title

بررسی اثربخشی اسورال در کاهش فریتین در بیماران با تالاسمی ماژور

فتحی, افشین and وفایی, مجید and امانی, فیروز and محبی, نادیا (1396) بررسی اثربخشی اسورال در کاهش فریتین در بیماران با تالاسمی ماژور. International Journal of Basic & Clinical Pharmacology ــ 6 (11). pp. 2556-2560. شاپا 2003-2319

[img]
Preview
Text
420kB

Official URL: http://www.ijbcp.com/index.php/ijbcp/article/view/...


Title

Evaluation of Osveral efficacy in reducing ferritin levels in patients with thalassemia major

English Abstract

Background: Beta thalassemia is one of the inherited blood diseases in which the production of specific chains in hemoglobin decreases. Esfarlal is a shaltor which is used in these patients as a single dose per day. Since it is prescribed orally, it is easier to tolerate the drug and control the serum iron level of the patient. The aim of this study was to evaluate the efficacy of Osveral in reducing ferritin levels in patients with thalassemia major. Methods: This quasi-experimental study was performed on 48 patients with thalassemia major who referred to Bu-Ali hospital for receiving blood. At the beginning of the study, the required data were collected along with patients' tests including hemoglobin, ferritin, TSH, T4, CBC diff, BUN AST, ALT, BS and creatinine CBC diff. The Osveral drug was prescribed and the patients were evaluated monthly for up to 6 months on the basis of complications. In the first three months after the start of the drug, the serum ferritin level was measured, the dose was adjusted and 6 months after late, the previous tests were again requested, and the auditory and visual examinations were performed, and the information entered the checklist. Data were analyzed using SPSS statistical software. Results: Among all patients, 27 (56.2%) were male and the rest were women with a mean age of 22.22 ± 8.77 years. The results showed that during one year of study, hemoglobin level increased and ferritin level decreased significantly, and other parameters didn’t show significant difference. Nausea and vomiting were the most common complications among patients, which was higher after Osveral than before receiving Osveral. Conclusions: Results showed that Osveral is effective in reducing the level of ferritin in patients with thalassemia major, but control of hematuria is recommended when using this drug.

Item Type:Article
زبان سند : انگلیسی
نویسنده اول :افشین فتحی
نویسنده مسئول :مجید وفایی
نویسنده :فیروز امانی
نویسنده :نادیا محبی
Additional Information:Indexed in: Index Copernicus
کلیدواژه ها (انگلیسی):Ferritin, Major thalassemia, Osveral
Subjects:WS Pediatrics
Divisions:Faculty of Medicine > Department of Pediatrics , Community Medicine
Faculty of Medicine > Department of Basic Sciences > Department of Vital Statistics
ID Code:9294
Deposited By: Dr Firouz Amani
Deposited On:07 Aug 1396 06:22
Last Modified:21 Feb 1399 15:20

Repository Staff Only: item control page

Document Downloads

More statistics for this item...